Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides a Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/21/2026

1. DSX
2. GNK
3. INTC
4. SPCX
5. III
6. TTEC
7. DAL
8. AWK
9. ATNI
10. SMG

Go back to Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides a Corporate Update
(NASDAQ: NRIX) Delayed: 17.55 +0.43 (2.51%)
Previous Close $17.12    52 Week High $ 
Open $17.64    52 Week Low $ 
Day High $17.89    P/E N/A 
Day Low $16.95    EPS $ 
Volume 4,250,981